Cost consequence analysis of adding semaglutide to treatment regimen for patients with Type II diabetes in Saudi Arabia by AlRuthia, Yazed, Hani Aburisheh, Khaled, Ata, Sondus, Bin Salleeh, Raghad, Alqudhibi, Shahad B., Alqudhibi, Raghad B., Alkraidis, Ziad, Humood Alkhalaf, Hala, Abdullah Almogirah, Abdulrahman, Mujammami, Muhammad, Al Khalifah, Reem

Get full text